Damien Saugy

Damien Saugy is a notable inventor based in Lausanne, Switzerland. He has made significant contributions to the field of biotechnology, particularly in gene transfer and expression in mammalian cells. With a total of three patents to his name, his work has the potential to impact various applications in genetic engineering and protein production.

Latest Patents

One of Damien Saugy's latest patents is titled "High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of MAR sequences." This invention relates to purified and isolated DNA sequences that enhance protein production activity, specifically through the use of matrix attachment regions (MARs) in eukaryotic cells. The patent also discloses a method for identifying these active regions, particularly MAR nucleotide sequences, and introduces a new multiple transfection method utilizing these characterized active MAR sequences.

Career Highlights

Damien Saugy is currently associated with Selexis S.A., a company known for its innovative approaches in the field of biopharmaceuticals. His work at Selexis has allowed him to explore and develop advanced methodologies for gene transfer, contributing to the company's mission of enhancing protein production in mammalian cells.

Collaborations

Throughout his career, Damien has collaborated with esteemed colleagues such as Pierre Alain Girod and Philipp Bucher. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Damien Saugy's contributions to biotechnology through his patents and work at Selexis S.A. highlight his role as a key innovator in gene transfer technology. His research continues to pave the way for advancements in protein production and genetic engineering.

Profile summary based on public USPTO records.